Kane Biotech Inc. KNBIF
Set alert
At close · Oct 30
- YTD
- -15.41%
- 1 year
- -22.41%
- Open
- 0.0225
- Prev close
- 0.0225
- Mkt cap
- 4.61M
- Vol
- 10.00K
- Avg vol
- 134.65K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.0225
- High
- 0.0225
News
1 week ago globenewswire.com
Kane Engages Independent Trading Group as Market Maker
Agreement intended to support an orderly market and improve liquidity in Kane Biotech's common shares Agreement intended to support an orderly market and improve liquidity in Kane Biotech's common…
1 week ago globenewswire.com
Kane Biotech Signs Distribution Agreement with The Stevens Company
Expands Kane Biotech's commercial footprint and access to the revyve ® product line across Canada
1 week ago globenewswire.com
Kane to Showcase revyve® at Wounds Canada National Hybrid Conference
Engaging Canadian wound-care professionals, presenting data and discussing biofilm management in clinical practice WINNIPEG, Manitoba, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE)…
1 week ago globenewswire.com
Kane Launches New Corporate Brand and Redesigned Website
Refreshed identity reflects Kane's focus on clinical biofilm science, advanced wound care and commercialization Refreshed identity reflects Kane's focus on clinical biofilm science, advanced wound…
2 weeks ago globenewswire.com
Kane Biotech Announces $250,000 Insider Loan
Unsecured, non-interest-bearing loan provides additional working capital support Unsecured, non-interest-bearing loan provides additional working capital support
3 weeks ago globenewswire.com
Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026
Company to engage with wound-care professionals and meet with existing and prospective distribution partners Company to engage with wound-care professionals and meet with existing and prospective…
1 month ago seekingalpha.com
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Transcript
1 month ago globenewswire.com
Kane Biotech to Host Commercial Update Webcast on September 16
Board Chair Philip Renaud, leading wound-care surgeon Dr. John C. Lantis and Interim CEO Dr. Robert Huizinga to discuss Kane's commercial progress, clinical relevance and operational priorities Board…
2 months ago globenewswire.com
Kane Biotech Announces Second Quarter 2026 Financial Results
WINNIPEG, Manitoba, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its second quarter 2026 financial results.
2 months ago globenewswire.com
Kane Biotech Announces Engagement of DNA Advisors
DNA Advisors brings expertise in capital markets, strategic transactions, partnerships, and growth initiatives DNA Advisors brings expertise in capital markets, strategic transactions, partnerships,…
4 months ago globenewswire.com
Kane Biotech Announces Results of Annual and Special Meeting of Shareholders
WINNIPEG, Manitoba, July 02, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) the voting results from its annual and special meeting of shareholders…
4 months ago seekingalpha.com
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript
5 months ago globenewswire.com
Kane Biotech Announces Grant of Stock Options
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 29, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the…
5 months ago globenewswire.com
Kane Biotech Announces First Quarter 2026 Financial Results
WINNIPEG, Manitoba, May 28, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its first quarter 2026 financial results.
5 months ago globenewswire.com
Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 26, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or…
5 months ago globenewswire.com
Kane Biotech Presents Data To Global Wound Care Community at WCET®–NSWOCC® 2026 Joint Congress
Case study presented highlighted clinical experience with revyve® in complex wound care Case study presented highlighted clinical experience with revyve® in complex wound care
5 months ago globenewswire.com
Kane Biotech Announces New Private Placement Offering
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 07, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the…
6 months ago globenewswire.com
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results.
7 months ago globenewswire.com
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms
WINNIPEG, Manitoba, March 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech” or “Kane”) announces that Frontiers in Antibiotics has published a peer-reviewed article authored…
7 months ago globenewswire.com
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
WINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (Kane or the Company), transforming wound care with three FDA 510(k) cleared and two Health Canada approved formats, is…
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Wednesday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday